Recent

• Math Over Myth: These Psychedelic Stocks Made Confirmed Bottoms in Q3
• Math Over Myth: Weekly Psychedelic Stocks News Roundup
• The Real Reason Cybin Bought Entheon’s DMT Clinical Trial
• This Week in Psychedelic Stocks: Compass Pathways Wins Patent Battle, MindMed Patents Candy Flipping, and More!
• Psychedelic Business Spotlight – June 17
• Psychedelic Business Spotlight – June 10
• 5 Next-Generation Psychedelics Entering Clinical Trials This Year
• Why Wednesday Will Be Biggest Day of 2022 for Psychedelic Investors
• Elon Musk Excites Psychedelic Industry CEOs with This Tweet
• My Favorite Psychedelic Stocks: Part 1